Patents by Inventor Gerd Klock

Gerd Klock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220160812
    Abstract: The invention relates to a pharmaceutically active substance comprising at least one peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion), characterised in that the pharmaceutically active substance comprises at least additional one amino acid and/or peptide portion at the N-terminal end and/or at the C-terminal end of the first peptide portion (second peptide portion and/or third peptide portion) being directly bound to the peptide portion having the amino acid sequences m-v-v-y-f-r (first peptide portion). The invention further relates to a pharmaceutical composition and a drug for the treatment of cancer.
    Type: Application
    Filed: May 18, 2020
    Publication date: May 26, 2022
    Inventors: Mark Andre Freyberg, Gerd Klock, Dirk Kaiser
  • Patent number: 9234896
    Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: January 12, 2016
    Assignee: CYTOTOOLS AG
    Inventors: Gerd Klock, Dirk Kaiser, Mark Andre Freyberg
  • Patent number: 7655773
    Abstract: The invention relates to anti-apoptotically active apatamers. The invention describes possible therapeutic and diagnostic applications for, among other things, treating arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases.
    Type: Grant
    Filed: December 10, 2004
    Date of Patent: February 2, 2010
    Assignee: CytoTools AG
    Inventors: Gerd Klock, Mark A. Freyberg, Dirk Kaiser
  • Publication number: 20080003563
    Abstract: A method for the isolation of specific molecules which bind highly selectively to chosen target molecules. In particular, due to displacement with a specific competitor, binding molecules are selected which preferably bind to previously known epitopes.
    Type: Application
    Filed: April 29, 2005
    Publication date: January 3, 2008
    Inventors: Gerd Klock, Dirk Kaiser, Mark Freyberg
  • Publication number: 20070117768
    Abstract: The invention relates to anti-apoptotically active apatamers. The invention describes possible therapeutic and diagnostic applications for, among other things, treating arteriosclerosis, promoting the healing of wounds, treating AIDS, cancer, Alzheimer's disease, systemic lupus erythematosus as well a rheumatoid arthritis and other chronic inflammatory diseases.
    Type: Application
    Filed: December 10, 2004
    Publication date: May 24, 2007
    Applicant: CYTOTOOLS GMBH
    Inventors: Gerd Klock, Mark Freyberg, Dirk Kaiser
  • Patent number: 6090793
    Abstract: Proposed is a mitogen-free substance comprising cross-linked copolymers including 10 to 90 mole % of guluronic acid, the balance being made up of mannuronic acid. The substance has a molecular weight of from 10,000 to 500,000 Daltons. Also proposed are methods for preparing such substances and their use.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: July 18, 2000
    Assignee: Monsanto Europe S.A.
    Inventors: Ulrich Zimmermann, Konrad Federlin, Tobias Zekorn, Gerd Klock